Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

BackgroundPirfenidone is an antifibrotic compound able to slow down disease progression in patients with idiopathic pulmonary fibrosis (IPF).ObjectiveTo investigate the safety and efficacy of pirfenidone in patients with IPF in a real-life setting.MethodsThis was a multicenter, retrospective, real-l...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Argyrios Tzouvelekis, Theodoros Karampitsakos, Paschalis Ntolios, Vasilios Tzilas, Evangelos Bouros, Evangelos Markozannes, Ioanna Malliou, Aris Anagnostopoulos, Andreas Granitsas, Paschalis Steiropoulos, Katerina Dimakou, Serafeim Chrysikos, Nikolaos Koulouris, Demosthenes Bouros
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-11-01
Subjects:	pirfenidone safety efficacy idiopathic pulmonary fibrosis treatment
Online Access:	http://journal.frontiersin.org/article/10.3389/fmed.2017.00213/full